{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:03:25Z","timestamp":1763665405534,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302"],"award-info":[{"award-number":["2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302","2021YFC2009300, 2021YFC2009302"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clozapine is a highly effective second-generation antipsychotic with few extrapyramidal reactions, making it a preferred choice among clinicians. However, instances of acute clozapine poisoning resulting from suicide attempts and misuse have been reported. Through our review of existing literature, we identified that we believe to be the highest recorded overdose of clozapine in elderly patients, resulting in a nonfatal outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The case report involves a 71-year-old female with a history of depression who ingested a dose of 10,000\u00a0mg of clozapine. Approximately 6\u00a0h after the overdose, the clozapine level was 5,200\u00a0\u03bcg\/L, significantly surpassing the recommended therapeutic concentration range of 350\u2013600\u00a0\u03bcg\/L. After gastric lavage and hemoperfusion, the blood level dropped to 1847.11\u00a0\u03bcg\/L. Notably, during therapeutic drugs monitoring (TDM), we found a perplexing spike in the patient\u2019s blood level to 5554.15\u00a0\u03bcg\/L after the second hemoperfusion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this case we mainly focused on the abnormal fluctuations in the concentration of clozapine. We conducted a comprehensive analysis of potential factors contributing to this abnormal phenomenon in terms of the patient\u2019s age, clinical symptoms, various laboratory test indexes, and the pharmacokinetics of clozapine. Our findings underscore the importance of timely TDM and the precision of results in managing elderly patients experiencing high-dose clozapine poisoning.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-024-05582-w","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:02:18Z","timestamp":1707908538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Abnormal blood concentration changes in a 71-year-old female who survived a 10,000mg overdose of clozapine: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yonghua","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"issue":"3","key":"5582_CR1","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","volume":"14","author":"FC Nucifora","year":"2017","unstructured":"Nucifora FC, Mihaljevic M, Lee BJ, Sawa A. Clozapine as a model for antipsychotic development. Neurotherapeutics. 2017;14(3):750\u201361.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"5582_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00004714-199404000-00006","volume":"14","author":"F Centorrino","year":"1994","unstructured":"Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol. 1994;14(2):119\u201325.","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"5582_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/14787210.2022.2110070","volume":"20","author":"I Martin-Loeches","year":"2022","unstructured":"Martin-Loeches I. Therapeutic drug monitoring (TDM) in real-time: a need for the present future. Expert Rev Anti Infect Ther. 2022;20(10):1245\u20137.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1\/2","key":"5582_CR4","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1\/2):9\u201362.","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"5582_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/j.1875-9114.1991.tb02628.x","volume":"11","author":"MW Jann","year":"1991","unstructured":"Jann MW. Clozapine. Pharmacotherapy. 1991;11(3):179\u201395.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"5582_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/acps.13264","volume":"143","author":"Y Yada","year":"2021","unstructured":"Yada Y, Kitagawa K, Sakamoto S, Ozawa A, Nakada A, Kashiwagi H, et al. The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study. Acta Psychiatr Scand. 2021;143(3):227\u201337.","journal-title":"Acta Psychiatr Scand"},{"key":"5582_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","volume":"192","author":"SR Clark","year":"2018","unstructured":"Clark SR, Warren NS, Kim G, Jankowiak D, Schubert KO, Kisely S, et al. Elevated clozapine levels associated with infection: a systematic review. Schizophr Res. 2018;192:50\u20136.","journal-title":"Schizophr Res"},{"issue":"2","key":"5582_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/JCP.0000000000001018","volume":"39","author":"CJ Ruan","year":"2019","unstructured":"Ruan CJ, Zang YN, Wang CY, Cheng YH, Sun C, Spina E, et al. Clozapine metabolism in East Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review. J Clin Psychopharmacol. 2019;39(2):135\u201344.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"5582_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/YIC.0b013e32835ac9da","volume":"28","author":"AP Rajkumar","year":"2013","unstructured":"Rajkumar AP, Poonkuzhali B, Kuruvilla A, Jacob M, Jacob KS. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Int Clin Psychopharmacol. 2013;28(1):50\u20136.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"5582_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","volume":"8","author":"D Telles-Correia","year":"2017","unstructured":"Telles-Correia D, Barbosa A, Cortez-Pinto H, Campos C, Rocha NBF, Machado S. Psychotropic drugs and liver disease: a critical review of pharmacokinetics and liver toxicity. World J Gastrointest Pharmacol Ther. 2017;8(1):26\u201338.","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"12","key":"5582_CR11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s40262-018-0664-3","volume":"57","author":"MC Mauri","year":"2018","unstructured":"Mauri MC, Paletta S, Di Pace C, Reggiori A, Cirnigliaro G, Valli I, et al. Clinical pharmacokinetics of atypical antipsychotics: an update. Clin Pharmacokinet. 2018;57(12):1493\u2013528.","journal-title":"Clin Pharmacokinet"},{"issue":"235","key":"5582_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2021.07.012","volume":"1","author":"CL Dias","year":"2021","unstructured":"Dias CL, Fonseca L, Gadelha A, Noto C. Clozapine-induced hepatotoxicity: a life threatening situation. Schizophr Res. 2021;1(235):3\u20134.","journal-title":"Schizophr Res"},{"issue":"2","key":"5582_CR13","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1097\/MJT.0000000000000715","volume":"25","author":"P Manu","year":"2018","unstructured":"Manu P, Lapitskaya Y, Shaikh A, Nielsen J. Clozapine rechallenge after major adverse effects: clinical guidelines based on 259 cases. Am J Ther. 2018;25(2):e218\u201323.","journal-title":"Am J Ther"},{"issue":"5","key":"5582_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/WNF.0b013e3181f0ec55","volume":"33","author":"I Kr\u00e4mer","year":"2010","unstructured":"Kr\u00e4mer I, Rauber-L\u00fcthy C, Kupferschmidt H, Kr\u00e4henb\u00fchl S, Ceschi A. Minimal dose for severe poisoning and influencing factors in acute human clozapine intoxication: a 13-year retrospective study. Clin Neuropharmacol. 2010;33(5):230\u20134.","journal-title":"Clin Neuropharmacol"},{"issue":"305","key":"5582_CR15","doi-asserted-by":"publisher","first-page":"114250","DOI":"10.1016\/j.psychres.2021.114250","volume":"1","author":"C Sahyouni","year":"2021","unstructured":"Sahyouni C, Hefazi E. Clozapine induced pericarditis: a case report. Psychiatry Res. 2021;1(305):114250.","journal-title":"Psychiatry Res"},{"issue":"239","key":"5582_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.schres.2021.11.007","volume":"1","author":"R Bagade","year":"2022","unstructured":"Bagade R, Karia S, Shah N, Andrade C. Surviving a 10,000 mg overdose of clozapine: a case report. Schizophr Res. 2022;1(239):31.","journal-title":"Schizophr Res"},{"issue":"1","key":"5582_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/JGP.0b013e3182118318","volume":"20","author":"Z Ismail","year":"2012","unstructured":"Ismail Z, Wessels AM, Uchida H, Ng W, Mamo DC, Rajji TK, et al. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia. Am J Geriatr Psychiatry. 2012;20(1):53\u201360.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"5582_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2125.1994.tb04385.x","volume":"38","author":"L Bertilsson","year":"1994","unstructured":"Bertilsson L, Carrillo JA, Dahl ML, Llerena A, Alm C, Bondesson U, et al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol. 1994;38(5):471\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"5582_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0278-5846(03)00148-9","volume":"27","author":"J de Leon","year":"2003","unstructured":"de Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(6):1059\u201363.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"5582_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00007691-199802000-00017","volume":"20","author":"D Reith","year":"1998","unstructured":"Reith D, Monteleone JPR, Whyte IM, Ebelling W, Holford NHG, Carter GL. Features and toxicokinetics of clozapine in overdose. Ther Drug Monit. 1998;20(1):92\u20137.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"5582_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1517\/14740338.4.4.731","volume":"4","author":"J Fitzsimons","year":"2005","unstructured":"Fitzsimons J, Berk M, Lambert T, Bourin M, Dodd S. A review of clozapine safety. Expert Opin Drug Saf. 2005;4(4):731\u201344.","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"5582_CR22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00134-022-06810-1","volume":"48","author":"Z Ricci","year":"2022","unstructured":"Ricci Z, Romagnoli S, Reis T, Bellomo R, Ronco C. Hemoperfusion in the intensive care unit. Intensive Care Med. 2022;48(10):1397\u2013408.","journal-title":"Intensive Care Med"},{"key":"5582_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-022-04009-w","volume":"26","author":"C Ronco","year":"2022","unstructured":"Ronco C, Bellomo R. Hemoperfusion: technical aspects and state of the art. Crit Care. 2022;26:135.","journal-title":"Crit Care"},{"issue":"2","key":"5582_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00414-014-1005-1","volume":"129","author":"J Maublanc","year":"2015","unstructured":"Maublanc J, Dulaurent S, Morichon J, Lach\u00e2tre G, Gaulier JM. Identification and quantification of 35 psychotropic drugs and metabolites in hair by LC-MS\/MS: application in forensic toxicology. Int J Legal Med. 2015;129(2):259\u201368.","journal-title":"Int J Legal Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05582-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05582-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05582-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:05:05Z","timestamp":1707908705000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05582-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5582"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05582-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our institutional review board granted consent for publishing encrypted information in this case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}